Document is current
Any future updates will be listed below
-
Authors
Grewal, Kabir
Dorff, Tanya B.
Mukhida, Sagar S.
Agarwal, Neeraj
Hahn, Andrew W.
- License Information
-
More Information
Article History
Accepted: 14 April 2025
First Online: 29 April 2025
Declarations
:
: KB and SSM have conflicts-of-interest to report. TBD reports consulting to Astella, AstraZeneca, Bayer, Blue Earth, Janssen, Novartis, and Pfizer. TBD reports institutional research funding from Amgen, AstraZeneca, and Abbvie. NA has no personal conflicts-of-interest since May 2021. In his lifetime, NA reports consulting to Astellas, AstraZeneca, AVEO, Bayer, Bristol Myers Squibb, Calithera, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Foundation Medicine, Genentech, Gilead, Janssen, Merck, MEI Pharma, Nektar, Novartis, Pfizer, Pharmacyclics, and Seattle Genetics. NA reports institutional funding from Arnivas, Astellas, AstraZeneca, Bavarian Nordic, Bayer, Bristol Myers Squibb, Calithera, Celldex, Clovis, Crispr, Eisai, Eli Lilly, EMD Serono, Exelixis, Genentech, Gilead, Glaxo Smith Kline, Immunomedics, Janssen, Lava, Medivation, Merck, Nektar, Neoleukin, New Link Genetics, Novartis, ORIC, Pfizer, Prometheus, Rexahn, Roche, Sanofi, Seattle Genetics, Takeda, and Tracon. AWH reports consulting to Janssen, Intellisphere, AVEO, Exelixis, Eisai, Pfizer, and Tolmar; honoraria from Medscape, Binaytara Foundation, Projects in Knowledge, Curio Science, Dava Oncology, and Mashup Media; and institutional research funding from Bayer, Eisai, and Halda Therapeutics.
